시장보고서
상품코드
1866582

AAV 벡터 트랜스펙션 키트 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

AAV Vector Transfection Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 AAV 벡터 트랜스펙션 키트 시장 규모는 2024년에 1억 7,700만 달러로 추정되며, 2025-2031년의 예측 기간 중 CAGR 25.9%로 확대하며, 2031년까지 8억 7,200만 달러에 달할 것으로 예측되고 있습니다.

이 보고서에서는 AAV 벡터 전달 키트의 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축, 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.

유전자 치료 제품의 임상연구에 대한 지속적인 승인과 함께 유전자 치료에 사용되는 바이러스 벡터가 널리 주목받고 있습니다. 아데노연관바이러스(AAV)는 저병원성, 저면역원성 및 넓은 숙주 범위와 안정적인 발현이라는 장점으로 인해 다른 많은 바이러스 벡터 중 가장 유망한 바이러스 벡터입니다. 임상 조사에서 폭넓게 응용되고 있습니다. AAV 벡터 개발에는 여러 가지 전략이 존재하지만, 대표적인 공정으로는 플라스미드 개발 및 생산, 세포배양, 플라스미드 도입, 바이러스 벡터 생산, 정제, 충전 및 마무리 등이 있습니다. 비정착 세포주 또는 부유 세포주에서 AAV 생산을 위한 일시적 도입 전략은 전임상 및 초기 개발 단계에서 가장 일반적입니다.

AAV(아데노연관바이러스) 벡터 전달 키트 시장은 유전자 치료 및 세포 기반 연구, 특히 유전질환, 암, 신경질환 치료 분야에서 급속한 성장세를 보이고 있습니다. AAV 벡터는 낮은 면역원성, 장기적인 유전자 발현, 안전성 프로파일로 인해 치료용 유전자 전달 수단으로 우선적으로 선택되고 있습니다. AAV 기반 치료법에 대한 임상 파이프라인이 확대됨에 따라 연구와 GMP 준수 제조를 모두 지원할 수 있는 효율적이고 신뢰할 수 있으며 확장성이 높은 트랜스펙션 키트에 대한 수요가 증가하고 있습니다. 또한 CRISPR과 같은 유전자 편집 기술을 연구하는 생명공학 기업 및 학술기관 증가는 다양한 세포 유형 및 생산 시스템에서 높은 전달 효율과 재현성을 원하는 연구자들에 의해 이러한 키트의 채택을 촉진하고 있습니다.

이 보고서는 AAV 벡터 전달 키트 세계 시장에 대해 총판매량, 판매 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하여 판매량(리터)과 매출액(백만 달러)으로 AAV 벡터 전송 키트 시장 규모, 추정 및 예측을 제공합니다. 정량적, 정성적 분석을 통해 독자들이 AAV 벡터 전달 키트 관련 사업/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

  • Thermo Fisher
  • Mirus Bio(Gamma)
  • Polyplus-transfection
  • Polysciences
  • Takara
  • Hanbio Biotechnology

유형별 부문

  • 소용량 포장
  • 중용량 포장
  • 대용량 포장

용도별 부문

  • 실험실
  • GMP 단계1-2

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSA 25.12.22

자주 묻는 질문

  • AAV 벡터 트랜스펙션 키트 시장 규모는 어떻게 예측되나요?
  • AAV 벡터 전달 키트의 주요 기업은 어디인가요?
  • AAV 벡터 전달 키트는 어떤 용도로 사용되나요?
  • AAV 벡터의 장점은 무엇인가요?
  • AAV 벡터 전달 키트의 시장 세분화는 어떻게 이루어지나요?

The global market for AAV Vector Transfection Kits was estimated to be worth US$ 177 million in 2024 and is forecast to a readjusted size of US$ 872 million by 2031 with a CAGR of 25.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on AAV Vector Transfection Kits cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research. There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development.

The market for AAV (Adeno-Associated Virus) Vector Transfection Kits is being driven by the rapid growth of gene therapy and cell-based research, particularly in the treatment of genetic disorders, cancers, and neurological diseases. AAV vectors are favored for their low immunogenicity, long-term gene expression, and safety profile, making them a preferred delivery vehicle for therapeutic genes. As clinical pipelines for AAV-based therapies expand, there is increasing demand for efficient, reliable, and scalable transfection kits that can support both research and GMP-compliant manufacturing. Furthermore, the rising number of biotech companies and academic institutions working on gene-editing technologies like CRISPR is fueling adoption of these kits, as researchers seek high transfection efficiency and reproducibility across various cell types and production systems.

This report aims to provide a comprehensive presentation of the global market for AAV Vector Transfection Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of AAV Vector Transfection Kits by region & country, by Type, and by Application.

The AAV Vector Transfection Kits market size, estimations, and forecasts are provided in terms of sales volume (Liter) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AAV Vector Transfection Kits.

Market Segmentation

By Company

  • Thermo Fisher
  • Mirus Bio (Gamma)
  • Polyplus-transfection
  • Polysciences
  • Takara
  • Hanbio Biotechnology

Segment by Type

  • Small Size Packaging
  • Medium Size Packaging
  • Large Size Packaging

Segment by Application

  • Laboratory
  • GMP Phase 1-2

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AAV Vector Transfection Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of AAV Vector Transfection Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of AAV Vector Transfection Kits in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 AAV Vector Transfection Kits Product Introduction
  • 1.2 Global AAV Vector Transfection Kits Market Size Forecast
    • 1.2.1 Global AAV Vector Transfection Kits Sales Value (2020-2031)
    • 1.2.2 Global AAV Vector Transfection Kits Sales Volume (2020-2031)
    • 1.2.3 Global AAV Vector Transfection Kits Sales Price (2020-2031)
  • 1.3 AAV Vector Transfection Kits Market Trends & Drivers
    • 1.3.1 AAV Vector Transfection Kits Industry Trends
    • 1.3.2 AAV Vector Transfection Kits Market Drivers & Opportunity
    • 1.3.3 AAV Vector Transfection Kits Market Challenges
    • 1.3.4 AAV Vector Transfection Kits Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global AAV Vector Transfection Kits Players Revenue Ranking (2024)
  • 2.2 Global AAV Vector Transfection Kits Revenue by Company (2020-2025)
  • 2.3 Global AAV Vector Transfection Kits Players Sales Volume Ranking (2024)
  • 2.4 Global AAV Vector Transfection Kits Sales Volume by Company Players (2020-2025)
  • 2.5 Global AAV Vector Transfection Kits Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers AAV Vector Transfection Kits Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers AAV Vector Transfection Kits Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of AAV Vector Transfection Kits
  • 2.9 AAV Vector Transfection Kits Market Competitive Analysis
    • 2.9.1 AAV Vector Transfection Kits Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by AAV Vector Transfection Kits Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Vector Transfection Kits as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Small Size Packaging
    • 3.1.2 Medium Size Packaging
    • 3.1.3 Large Size Packaging
  • 3.2 Global AAV Vector Transfection Kits Sales Value by Type
    • 3.2.1 Global AAV Vector Transfection Kits Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global AAV Vector Transfection Kits Sales Value, by Type (2020-2031)
    • 3.2.3 Global AAV Vector Transfection Kits Sales Value, by Type (%) (2020-2031)
  • 3.3 Global AAV Vector Transfection Kits Sales Volume by Type
    • 3.3.1 Global AAV Vector Transfection Kits Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global AAV Vector Transfection Kits Sales Volume, by Type (2020-2031)
    • 3.3.3 Global AAV Vector Transfection Kits Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global AAV Vector Transfection Kits Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Laboratory
    • 4.1.2 GMP Phase 1-2
  • 4.2 Global AAV Vector Transfection Kits Sales Value by Application
    • 4.2.1 Global AAV Vector Transfection Kits Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global AAV Vector Transfection Kits Sales Value, by Application (2020-2031)
    • 4.2.3 Global AAV Vector Transfection Kits Sales Value, by Application (%) (2020-2031)
  • 4.3 Global AAV Vector Transfection Kits Sales Volume by Application
    • 4.3.1 Global AAV Vector Transfection Kits Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global AAV Vector Transfection Kits Sales Volume, by Application (2020-2031)
    • 4.3.3 Global AAV Vector Transfection Kits Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global AAV Vector Transfection Kits Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global AAV Vector Transfection Kits Sales Value by Region
    • 5.1.1 Global AAV Vector Transfection Kits Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global AAV Vector Transfection Kits Sales Value by Region (2020-2025)
    • 5.1.3 Global AAV Vector Transfection Kits Sales Value by Region (2026-2031)
    • 5.1.4 Global AAV Vector Transfection Kits Sales Value by Region (%), (2020-2031)
  • 5.2 Global AAV Vector Transfection Kits Sales Volume by Region
    • 5.2.1 Global AAV Vector Transfection Kits Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global AAV Vector Transfection Kits Sales Volume by Region (2020-2025)
    • 5.2.3 Global AAV Vector Transfection Kits Sales Volume by Region (2026-2031)
    • 5.2.4 Global AAV Vector Transfection Kits Sales Volume by Region (%), (2020-2031)
  • 5.3 Global AAV Vector Transfection Kits Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America AAV Vector Transfection Kits Sales Value, 2020-2031
    • 5.4.2 North America AAV Vector Transfection Kits Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe AAV Vector Transfection Kits Sales Value, 2020-2031
    • 5.5.2 Europe AAV Vector Transfection Kits Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific AAV Vector Transfection Kits Sales Value, 2020-2031
    • 5.6.2 Asia Pacific AAV Vector Transfection Kits Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America AAV Vector Transfection Kits Sales Value, 2020-2031
    • 5.7.2 South America AAV Vector Transfection Kits Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa AAV Vector Transfection Kits Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa AAV Vector Transfection Kits Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions AAV Vector Transfection Kits Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions AAV Vector Transfection Kits Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions AAV Vector Transfection Kits Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.3.2 United States AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.4.2 Europe AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.5.2 China AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.6.2 Japan AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.7.2 South Korea AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.8.2 Southeast Asia AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India AAV Vector Transfection Kits Sales Value, 2020-2031
    • 6.9.2 India AAV Vector Transfection Kits Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India AAV Vector Transfection Kits Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher
    • 7.1.1 Thermo Fisher Company Information
    • 7.1.2 Thermo Fisher Introduction and Business Overview
    • 7.1.3 Thermo Fisher AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Thermo Fisher AAV Vector Transfection Kits Product Offerings
    • 7.1.5 Thermo Fisher Recent Development
  • 7.2 Mirus Bio (Gamma)
    • 7.2.1 Mirus Bio (Gamma) Company Information
    • 7.2.2 Mirus Bio (Gamma) Introduction and Business Overview
    • 7.2.3 Mirus Bio (Gamma) AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Mirus Bio (Gamma) AAV Vector Transfection Kits Product Offerings
    • 7.2.5 Mirus Bio (Gamma) Recent Development
  • 7.3 Polyplus-transfection
    • 7.3.1 Polyplus-transfection Company Information
    • 7.3.2 Polyplus-transfection Introduction and Business Overview
    • 7.3.3 Polyplus-transfection AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Polyplus-transfection AAV Vector Transfection Kits Product Offerings
    • 7.3.5 Polyplus-transfection Recent Development
  • 7.4 Polysciences
    • 7.4.1 Polysciences Company Information
    • 7.4.2 Polysciences Introduction and Business Overview
    • 7.4.3 Polysciences AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Polysciences AAV Vector Transfection Kits Product Offerings
    • 7.4.5 Polysciences Recent Development
  • 7.5 Takara
    • 7.5.1 Takara Company Information
    • 7.5.2 Takara Introduction and Business Overview
    • 7.5.3 Takara AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Takara AAV Vector Transfection Kits Product Offerings
    • 7.5.5 Takara Recent Development
  • 7.6 Hanbio Biotechnology
    • 7.6.1 Hanbio Biotechnology Company Information
    • 7.6.2 Hanbio Biotechnology Introduction and Business Overview
    • 7.6.3 Hanbio Biotechnology AAV Vector Transfection Kits Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Hanbio Biotechnology AAV Vector Transfection Kits Product Offerings
    • 7.6.5 Hanbio Biotechnology Recent Development

8 Industry Chain Analysis

  • 8.1 AAV Vector Transfection Kits Industrial Chain
  • 8.2 AAV Vector Transfection Kits Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 AAV Vector Transfection Kits Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 AAV Vector Transfection Kits Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제